Bookmark and Share
DL-Cysteine (CID 594) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(22)
 
 
Inactive(155)
 
 
Inconclusive(47)
 
 
Unspecified(13)
 
 
Top Targets:
NR LBD PPAR(8)
 
 
NR LBD AR(7)
 
 
NR LBD ER(7)
 
 
NR LBD TR(5)
 
 
PLDc mTdp1 2(5)
 
 
 
BioAssay Types:
Confirmatory(122)
 
 
 
 
 
Literature(73)
 
 
 
 
 
Summary(24)
 
 
Screening(4)
 
 
 
BioActivity Types:
Potency(136)
 
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 162    Data Row: 237   Total Pages: 12   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID29216046]
Potency 4.2562Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory]
View
2
[SID29216046]
Potency 15.8489qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory]euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070]
View
3
[SID29216046]
Potency 17.7828qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory]phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339]
View
4
[SID29216046]
Potency 44.6684Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
5
[SID14720397]
Compound Screen Assay, Human CENTG1 [AID511, Type: screening]arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 isoform PIKE-A [Homo sapiens] [gi:7661962]
View
6
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_3, Type: Literature]
View
7
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_7, Type: Literature]
View
8
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_8, Type: Literature]
View
9
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_1, Type: Literature]
View
10
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_13, Type: Literature]
View
11
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_15, Type: Literature]
View
12
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_19, Type: Literature]
View
13
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_20, Type: Literature]
View
14
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_21, Type: Literature]
View
15
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_34, Type: Literature]
View
16
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_39, Type: Literature]
View
17
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_52, Type: Literature]
View
18
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_53, Type: Literature]
View
19
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_54, Type: Literature]
View
20
[SID29216046]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_55, Type: Literature]
View